Mevion has benefited from Dr. Lawrence Tian’s leadership as a member of the board of directors since 2015 and was appointed Chairman in 2018. Dr. Tian brings a wealth of experience from the life sciences and medical device industry to this role. He is a Founding Partner of YuanMing Capital, a leading private equity firm which focuses on the investment in pharmaceutical research and development, innovative medical devices and high-end medical services in both China and the United States. He also serves as the Chairman of Investment Committee of China Pharmaceutical Industry Research and Development Association, and he is a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited.
Dr. Tian also brings experience networking business leaders to the Mevion leadership team. He is the founder and Chairman of the China Entrepreneurs Forum, the most influential business owners association in China, and is the founder of the China-U.S. Business Leaders Roundtable, a prestigious cross-border communication platform.
Prior to Mevion, Dr. Tian has had successful career as a serial entrepreneur with a strong track record of success. In the financial markets, he founded China International Futures Co., Ltd. (CIFCO) in 1992. CIFCO grew into a leading brokerage firm and achieved the largest market share in China during his chairmanship. He also co-founded Wumart Group in 1994, which is currently the largest supermarket chain in Northern China.
Dr. Tian obtained his master’s degree and doctoral degree from Wuhan University. He received the China Economics Theory Innovation Award, China’s highest prize for economics.